Ticker
LPTXCompany Name
LEAP THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 20.04M | $ 18.91M | 94.37% |
3/31/2025 | $ 34.88M | $ 33.52M | 96.09% |
12/31/2024 | $ 49.12M | $ 48.07M | 97.86% |
9/30/2024 | $ 65.05M | $ 63.69M | 97.91% |
6/30/2024 | $ 81.43M | $ 79.34M | 97.44% |
3/31/2024 | $ 57.96M | $ 55.84M | 96.33% |
12/31/2023 | $ 72.83M | $ 71.61M | 98.33% |
9/30/2023 | $ 83.05M | $ 81.66M | 98.33% |
6/30/2023 | $ 95.86M | $ 92.35M | 96.34% |
3/31/2023 | $ 106.55M | $ 103.01M | 96.68% |
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for LEAP THERAPEUTICS INC is calculated as follows: CashnEq [ $ 58.92M ] / Assets [ $ 60.54M ]
(=) Cash to Assets [ 97.31% ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.71% |
average | 9.76% |
median | 6.41% |
std | 9.51% |